Loading ...

Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

α-peptide/antigen peptide-loaded 1,2-dimyristoyl-sn-glycero-3-phosphocholine/1,2-distearoyl-sn-glycero-3-phosphatidylethanolamine-poly(ethylene glycol)/cholesterol oleate nanoparticles labeled with FAM

Based on

1 Articles
2016 Most recent source

Composition

1

cholesterol oleate

cholesteryl oleate CO
Type Single Compound
Formula C45H78O2
Role core
2

1,2-dimyristoyl-sn-glycero-3-phosphocholine/1,2-distearoyl-sn-glycero-3-phosphatidylethanolamine-poly(ethylene glycol)

DMPC/DSPE-PEG2000
Type Complex Compound
Formula
Role layer
3

α-peptide/antigen peptide

α-Ap
Type Biomolecule
Formula
Role loaded material
4

3',6'-dihydroxy-3H-spiro[2-benzofuran-1,9'-xanthene]-3-one

fluorescein free acid fluorescein dye fluorescein Flu dye Fluo FAM FSN
Type Single Compound
Formula C20H12O5
Role loaded material

Properties

Applications

Area Application Nanomaterial Variant Source
medicine/veterinary

More information available to subscribers only.

Or, view sample content

Characterization

Method Nanomaterial Variant Source
dynamic light scattering

More information available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Nanomaterial Variant Source
CX<sub>3</sub>CR<sub>1</sub><sup>gfp/+</sup> transgenic C57BL/6 mouse

More information/entries available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • 1,2-distearoyl-sn-glycero-3-phosphatidylethanolamine-poly(ethylene glycol)
  • 1,2-ditetradecanoyl-sn-glycero-3-phosphocholine
  • cholesterol oleate
  1. 3qBIm7RiYhsqheTm2jD
Product

α-peptide/antigen peptide-loaded 1,2-dimyristoyl-sn-glycero-3-phosphocholine/1,2-distearoyl-sn-glycero-3-phosphatidylethanolamine-poly(ethylene glycol)/cholesterol oleate nanoparticles labeled with FAM

Hydrodynamic diameter: ~ 21.9 nm

Medium: phosphate buffer solution

Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial